Gene Query: DPYSL3

Dataset Description Geneva Score
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 190.93
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 190.93
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 125.2
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 115.42
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 110.63
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 100.74
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 100.51
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 98.33
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 87.91
Inhibition of TNBC metastasis by Gpx1 85.73
Genome-wide functional assessment of enhancer activities in the human genome 85.45
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 80.77
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 70.83
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 66.95
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 66.56
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 66.37
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 63.88
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 63.88
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 62.01
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 61.84
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 60.96
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 59.85
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 58.89
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 57.93
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 57.93
RNA-seq of cells with TET1 knockout 52.48
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 52.14
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 51.89
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 51.89
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 51.8
AMPK signaling for naïve pluripotency 51.16
AMPK signaling for naïve pluripotency [Hs] 51.16
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 50.32
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 50.32
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 50.18
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 49.88
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 49.19
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 49.18
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 48.98
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 48.97
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 47.48
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 47.3
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 47.14
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 46.34
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 45.65
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 44.65
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 44.49
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 42.95
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 42.02
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 41.81
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 41.53
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 41.36
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 41.36
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 41.23
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 40.76
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 40.58
HEK293 TFAM Knockout Expression Study 38.62
Gene expression analysis of immortalized human liver progenitor-like cells in culture 38.62
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 38.57
The cohesin release factor WAPL restricts chromatin loop extension. 38.24
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 38.24
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 38.2
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 37.62
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 37.58
Generation of KRAS signatures using immortalized isogenic lung cells. 37.34
Anti-inflammatory effect of indoleacrylic acid (IA) 36.77
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 36.6
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 36.25
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 36.13
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 36.13
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 35.98
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 35.64
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 35.47
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 35.19
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 35.14
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 35.07
Identification of differentially expressed genes between senescence and senescence bypass cells 34.57
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 34.42
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 34.22
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 34.16
MARS Seq data from human cortical organoids 33.54
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 33.5
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 32.72
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 32.56
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 31.83
Evolution of a transcriptional regulator from a transmembrane nucleoporin 31.59
RNA-seq in HepG2 and IMR90 cells 31.59
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 31.21
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 31.01
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 30.96
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 30.96
UBC9 knockdown in bladder cancer T24 cell lines 30.93
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 30.81
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 30.43
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 30.33
RNA-seq of naive and primed ES cells 30.2
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 30.17
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 30.17
The Genomic Landscape of Atypical Fibroxanthoma 30.15
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 29.87
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 29.57
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 29.57
RNA-seq of shEZH2 cells 29.52
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 29.18
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 29.08
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 28.8
Differential expression of genes in AD169-infected MRC5. 28.72
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 28.66
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 28.56
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 28.35
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 28.24
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 27.94
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 27.81
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 27.81
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 27.72
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 27.72
Gene Expression Profiling of SPOP Knocked Down Cell 27.39
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 27.26
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 27.21
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 27.07
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 26.98
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 26.8
RNA-Seq from early time points in the kidney differentiation protocol 26.73
RNA-seq of MCF10A cells and CAF 26.66
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 26.61
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 26.61
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 26.6
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 26.52
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 26.23
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 26.08
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 26.08
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 26.06
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 26.04
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 25.78
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 25.78
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 25.77
Epigenomic landscape during organ formation in human early embryos 25.58
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 25.49
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 25.45
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 25.41
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 25.04
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 24.98
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 24.98
Transcriptomic and gene ontology profiling of the human corneal cell types 24.76
Effect of mitochondria deficiency on senescence-associated gene expression 24.75
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 24.72
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 24.52
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 24.41
MicroRNA targetome analysis during HCMV infection 24.4
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 24.27
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 24.21
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 23.96
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 23.82
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  23.79
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 23.75
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 23.63
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 23.59
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 23.38
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 23.28
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 23.28
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 23.15
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 23.04
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 23.01
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 22.7
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 22.7
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 22.7
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 22.65
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 22.59
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 22.54
Spliceosomal disruption of the non-canonical BAF complex in cancer 22.53
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 22.48
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 22.43
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 22.06
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 22.06
Total RNA sequencing of APC mutant and wt colonic organoids 21.96
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 21.95
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 21.82
Gene expression patterns define the hepatocyte-like cells derived by different strategies 21.73
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 21.73
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 21.67
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 21.67
JAK dependent survival of ALK- ALCL 21.66
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 21.5
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 21.39
RNA-seq of human fibroblasts after irradiation 21.33
Differentiation enhances Zika virus infection in neuronal brain cells 21.3
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 21.02
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 20.96
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 20.94
RNA-seq of human aneuploid cell lines with Trisomy 21 20.9
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 20.65
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 20.14
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 20.14
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 20.08
Epigenome regulation during epidermal lineage commitment 20.05
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 20.02
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 20.0
Global analyses of the effect of different cellular contexts on microRNA targeting 20.0
The interplay between SOX4 and SMAD3 in the context of breast cancer 19.98
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 19.97
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 19.78
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 19.71
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 19.6
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 19.6
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 19.41
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 19.41
RNA seq comparison between scrambled and shGRP78 cells 19.38
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 19.34
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 19.33
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 19.31
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 19.3
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 19.18
Chromatin landscape of human visceral and subcutaneous adipocytes 19.1
RNA Sequencing of three pairs of gastric cancer 19.1
RNA sequencing with KSHV infection and enrichment for circular RNAs 19.02
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 18.87
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 18.81
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 18.79
Non-coding regions are the main source of tumor-specific antigens 18.77
Non-coding regions are the main source of tumor-specific antigens [human] 18.77
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 18.74
Postnatal lipids drive hepatocyte maturation 18.73
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 18.54
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 18.54
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 18.44
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 18.44
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 18.42
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 18.4
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 18.27
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 18.16
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 18.16
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 18.07
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 18.07
MEIS1 regulates hematopoiesis in hPSCs 18.04
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 18.04
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 18.03
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 18.0
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 17.94
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 17.94
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 17.9
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 17.9
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 17.88
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 17.88
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 17.88
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 17.82
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 17.78
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 17.78
RNAseq Analysis in glioblastoma cells treated with Mepazine 17.75
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 17.66
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 17.58
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 17.57
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 17.52
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 17.47
Paxillin regulates genomic networks in prostate cancer [PC3] 17.42
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 17.33
TGF-β promotes genomic instability after loss of RUNX3 17.31
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 17.24
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 17.21
Expression profiling of etoposide-induced senescent cells 17.17
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 17.04
Epigenome regulation during epidermal lineage commitment [RNA-seq] 17.04
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 17.02
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 16.81
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 16.74
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 16.73
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 16.7
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 16.62
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 16.53
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 16.51
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 16.51
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 16.42
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 16.37
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 16.37
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 16.35
Comparison of microRNA Profiling Platforms 16.31
Comparison of microRNA Profiling Platforms (HTS) 16.31
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 16.26
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 16.26
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 16.18
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 16.08
Global analysis of alternative splicing regulated by RBM10 16.04
Genome-wide chromatin analysis of Ewing sarcoma 15.99
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 15.99
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 15.89
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 15.89
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 15.88
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 15.81
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 15.78
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 15.73
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 15.72
A sister of NANOG regulates genes expressed in pre-implantation human development 15.72
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 15.56
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 15.53
15.45
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 15.32
Biological effect of chronic mistranslation in mammalian cells 15.22
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 15.22
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 15.21
Entrectinib Resistance in a Neuroblastoma Xenograft Model 15.08
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 15.01
A prostate cancer chromatin interaction map 14.89
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 14.88
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 14.88
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 14.88
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 14.7
Depicting early human development and germ cell origin with porcine embryos 14.68
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 14.65
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 14.63
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 14.63
DJ-1 is dispensable for human stem cell homeostasis 14.49
Gene expression profile in breast cancer cell lines using RNA sequencing 14.48
Morphological and molecular characterization of human dermal lymphatic collectors 14.42
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 14.38
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 14.27
RNA Seq of HMVEC under hypoxia 14.27
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 14.27
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 14.08
Gene profiling of human adult and pediatric liver cancer cells 13.97
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 13.87
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 13.79
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 13.73
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 13.71
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 13.69
mRNA sequencing of oropharyngeal cancer cell lines 13.68
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 13.63
circNFIB suppresses lymphatic metastasis of pancreatic cancer 13.59
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 13.58
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 13.52
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 13.45
TOP2B disturbed the quality of human oocytes with advanced maternal age 13.37
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 13.32
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 13.16
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 12.97
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 12.95
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 12.95
STX4 Over-Expression in Human islets 12.81
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 12.6
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 12.59
A code of mono-phosphorylation modulates the function of RB. 12.58
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 12.52
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 12.37
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 12.31
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 12.2
The gene expression profiles of gallbladder cancer 12.08
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 12.07
Modeling Familial Cancer with iPSC Approaches 11.95
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 11.87
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 11.7
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 11.62
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 11.55
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 11.53
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 11.33
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 11.31
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 11.22
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 11.22
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 11.11
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 11.1
Molecular Criteria for Defining the Naive Human Pluripotent State 10.92
TGF-β regulation of miRNA expression in pancreatic cancer 10.67
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 10.55
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 10.52
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 10.51
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 10.27
Gene expression changes in human melanoma cell lines compared to primary melanocytes 10.25
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 10.15
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 10.02
circRNA profile in hypopharyngeal cancer 10.0
Gene expression profiling of human and murine in vitro muscle differentiation 9.91
iPSC-Derived Cholangiocytes 9.79
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 9.31
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 9.3
Trascriptome of thyroid cancer-induced macrophages 9.28
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 9.2
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 9.07
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 9.07
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 8.97
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 8.63
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 8.63
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 8.54
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 8.54
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 8.53
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 8.5
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 8.5
RNA-Seq of Breast and Ovarian Cancer Cell Lines 8.48
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 8.36
Modeling Human Cancer-induced Cachexia (Human) 8.34
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 8.12
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 8.11
Effect of nuclear IL-33 on gene expression 7.9
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 7.75
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 7.74
Transcriptome profiling of 5 human adenocarcinoma cell lines 7.73
Transcriptome analysis of human lung epithelial cells 7.69
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 7.6
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 7.47
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 7.44
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 7.23
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.08
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 7.07
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 6.89
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 6.87
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 6.84
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 6.84
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 6.73
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 6.58
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 6.58
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 6.56
Single cell transcriptome of peritoneal cells 6.55
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 6.48
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 6.46
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 6.41
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 6.4
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 6.4
RNA-sequencing of healthy human skeletal myocytes 6.33
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 6.31
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 6.31
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 6.31
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 6.13
Identification of the role of polydom in neurofibromas 6.06
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 5.72
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 5.69
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 5.69
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 5.66
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 5.66
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 5.55
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 5.41
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 5.41
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 5.41
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 5.36
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 5.13
Gene expression regulated by CSA and CSB in neuroblastoma cell line 4.92
Transcriptomes in healthy and CHB fetal hearts 4.91
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 4.86
In vitro modeling of human germ cell development using pluripotent stem cells 4.84
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 4.81
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 4.81
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 4.63
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 4.63
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 4.62
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 4.62
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 4.58
Expression profiling of converted and control dermal BJ fibroblasts 4.57
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 4.57
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 4.36
Widespread regulated alternative splicing of single codons accelerates proteome evolution 4.35
Aneuploidy-induced cellular stresses limit autophagic degradation. 4.3
RNA-seq of cancer cell lines treated with T-025 4.3
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 3.82
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 3.81
Aortic Valve Tissue: Stenosis vs. Sclerosis 3.76
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 3.75
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 3.75
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 3.56
RNA seq_PDX2_SHP099 3.55
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 3.41
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 3.26
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 3.24
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 3.24
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 3.14
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 3.07
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 2.68
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.61
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.57
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 2.44
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 2.37
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.37
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 2.23
Transcriptome-wide response to synthetic chromatin protein PcTF 2.14
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.92
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.59
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.59
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.53
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.53
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.53
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.47
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.31
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.06
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.04
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.0
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.88
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.84
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.82
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.78
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.72
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.67
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 0.64
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.59
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.53
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 0.52
Metabolism as an early predictor of DPSCs aging 0.43
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.41
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.41
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.41
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.35
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.31
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.26
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.26
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.12
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.08
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation